Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ris-Hep Study"'
Autor:
Dolores Merino, Lucio García-Fraile, Alejandro González-Serna, Gehep study groups, Juan Macías, Francisco Téllez, Luis Morano, Ignacio Santos, Ris-Hep Study, Federico García, Francisco Jesús Vera-Méndez, Luis Miguel Real, Rafael Granados, Juan A. Pineda, Esther Campo-Moneo
Publikováno v:
Journal of viral hepatitisREFERENCES. 28(6)
Elbasvir/grazoprevir (EBR/GZR) use in drug users on opiate agonist therapy (OAT) is supported by the C-EDGE Co-STAR trial. SVR rates in this study were within those found in the rest of patients included by the EBR/GZR development programme. In clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44b8303169bdf76e45fe3f01b0fce3cc
https://pubmed.ncbi.nlm.nih.gov/33721377
https://pubmed.ncbi.nlm.nih.gov/33721377
Autor:
José Miguel Dávila Martín, Juan A. Pineda, Luis E. Morano-Amado, E N Álvarez, Montserrat Pérez-Pérez, R Sarmento E Castro, Juan Macías, Ris-Hep study groups, M.J. Ríos, M J Álvarez-Ossorio, J Mendez, Dolores Merino, Rafael Granados, Francisco Téllez, Karin Neukam, Antonio Collado, Hepavir-Daa, Gehep-Mono, Ris-Hep
Publikováno v:
Journal of Viral Hepatitis. 25:699-706
Little data are available on renal toxicity exerted by direct-acting antivirals (DAAs) in real life. The aim of this study was to assess the impact of direct-acting antivirals against hepatitis C virus infection currently used in Spain and Portugal o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09d4d2ffd10616d178b9faa29586d345
https://doi.org/10.1111/jvh.12867
https://doi.org/10.1111/jvh.12867